774 related articles for article (PubMed ID: 24287311)
1. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.
Varbo A; Benn M; Nordestgaard BG
Pharmacol Ther; 2014 Mar; 141(3):358-67. PubMed ID: 24287311
[TBL] [Abstract][Full Text] [Related]
2. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
3. Remnant cholesterol and ischemic heart disease.
Varbo A; Nordestgaard BG
Curr Opin Lipidol; 2014 Aug; 25(4):266-73. PubMed ID: 24977981
[TBL] [Abstract][Full Text] [Related]
4. Remnant cholesterol as a causal risk factor for ischemic heart disease.
Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
[TBL] [Abstract][Full Text] [Related]
5. Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease.
Varbo A; Benn M; Smith GD; Timpson NJ; Tybjaerg-Hansen A; Nordestgaard BG
Circ Res; 2015 Feb; 116(4):665-73. PubMed ID: 25411050
[TBL] [Abstract][Full Text] [Related]
6. A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals.
Balling M; Langsted A; Afzal S; Varbo A; Davey Smith G; Nordestgaard BG
Atherosclerosis; 2019 Jul; 286():97-104. PubMed ID: 31108411
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
Nordestgaard BG
Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a), cardiovascular disease, and contemporary management.
Jacobson TA
Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706
[TBL] [Abstract][Full Text] [Related]
9. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
[TBL] [Abstract][Full Text] [Related]
10. Triglycerides, high-density lipoprotein cholesterol, and risk of ischemic heart disease: a view from the Copenhagen Male Study.
Jeppesen J
Metab Syndr Relat Disord; 2003 Mar; 1(1):33-53. PubMed ID: 18370624
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerotic risk factors in cardiovascular disease.
LaRosa JC
J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
[TBL] [Abstract][Full Text] [Related]
12. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
14. Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?
Wadström BN; Wulff AB; Pedersen KM; Nordestgaard BG
Curr Atheroscler Rep; 2023 Nov; 25(11):795-803. PubMed ID: 37768410
[TBL] [Abstract][Full Text] [Related]
15. Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population.
Varbo A; Freiberg JJ; Nordestgaard BG
Clin Chem; 2015 Mar; 61(3):533-43. PubMed ID: 25605681
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
17. [Triglyceride (TG) and remnant lipoproteins].
Yoshida H; Kisugi R; Koike M; Kurosawa H
Rinsho Byori; 2012 Apr; 60(4):343-8. PubMed ID: 22686044
[TBL] [Abstract][Full Text] [Related]
18. Remnant lipoproteins and atherosclerotic cardiovascular disease.
Tada H; Nohara A; Inazu A; Mabuchi H; Kawashiri MA
Clin Chim Acta; 2019 Mar; 490():1-5. PubMed ID: 30553862
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
[TBL] [Abstract][Full Text] [Related]
20. Reply to letters regarding article, "Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation".
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2014 Jun; 129(24):e656. PubMed ID: 24934470
[No Abstract] [Full Text] [Related]
[Next] [New Search]
